Physician profile
Todd R Becker
NPI 1558377143
$2,784.01
in general payments reported to CMS, 2019-2025
26 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $91.26 · 2021: $378 · 2022: $318 · 2023: $455 · 2024: $1,005 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041 · Travel and Lodging: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.26 |
| Travel and Lodging | $767.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $509.69 | 2021-2024 | |
| Arthrex, INC. | $471.35 | 2024 | |
| Smith+Nephew, INC. | $306.93 | 2019-2025 | Collagenase Santyl, Regranex, Bone Anchors With Arthroscopic Delivery System |
| Abbvie INC. | $242.79 | 2022-2025 | Dalvance |
| Organogenesis INC. | $229.78 | 2019-2023 | Puraply |
| Paragon 28, INC. | $94.21 | 2021 | |
| Depuy Synthes Sales INC. | $91.48 | 2023-2025 | Motoband, Quickanchor Ethibond, Dynacord |
| Globus Medical, INC. | $81.21 | 2025 | Senza |
| Horizon Therapeutics Plc | $69.22 | 2020-2023 | Krystexxa |
| Solventum Corporation | $63.97 | 2025 | V.A.C.Ulta, Prevena, Activ.A.C. |
| Trice Medical, INC. | $63.59 | 2023 | |
| Mimedx Group, INC. | $62.62 | 2024 | |
| Convatec INC. | $53.73 | 2024-2025 | |
| Averitas Pharma INC. | $52.65 | 2023-2025 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $52.41 | 2022-2023 | Seglentis |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $50.67 | 2022-2023 | Senza |
| Melinta Therapeutics, LLC | $50.14 | 2019-2022 | |
| Amgen INC. | $42.47 | 2024-2025 | Krystexxa |
| Acera Surgical, INC. | $37.13 | 2021-2023 | Restrata Wound Matrix |
| Medtronic, INC. | $31.87 | 2023 | Intellis Adaptivestim |
| Kci USA, INC. | $30.96 | 2020-2022 | |
| Next Science LLC | $25.21 | 2023 | Blastx, Xperience, Surgx |
| Biocomposites INC | $20.99 | 2025 | Stimulan |
| Ibsa Pharma INC. | $19.56 | 2024 | Tirosint, Licart |
| Merck Sharp & Dohme LLC | $15.28 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.10 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.